GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve

GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve

ObjectiveTo evaluate the efficiency and validity of cessation of cetrorelix on trigger day during gonadotropin releasing hormone antagonist (GnRH-ant)-controlled ovarian stimulation of in vitro fertilization (IVF) cycles.MethodsIn this retrospective study, a total of 1271 patients undergoing initial...

Full description

Bibliographic Details
Main Authors: Huihui Xu, Shen Zhao, Xinxing Gao, Xian Wu, Lan Xia, Dan Zhang, Jian Li, Aijun Zhang, Bufang Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Endocrinology
Subjects:
GnRH-ant protocol
cetrorelix
trigger day
embryological outcomes
clinical outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.758896/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.758896/full

Similar Items